Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sushree Mohanty

This AI Biotech Stock Landed a $10.4 Million Nvidia Investment

When chip giant Nvidia (NVDA) shows interest in any company, analysts and investors take note. According to Nvidia’s most recent 13F filing, the company now owns 833,325 shares of AI biotech company Generate Biomedicines (GENB), with the position valued at around $10.4 million.

This investment might be small for Nvidia with its massive balance sheet and multi-billion-dollar AI infrastructure bets. However, for a small clinical-stage biotech company, Nvidia’s trust and investment could carry a lot of significance. GENB stock went public in late February 2026 and has already earned a “Strong Buy” consensus rating on Wall Street, despite rising just 8% from its opening price of $12.01 on March 2.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.